Publication: Mesalazine induced interstitial pneumonitis in the COVID era.
Loading...
Identifiers
Date
2022
Authors
Aparicio Serrano, Ana
Gallego Jimenez, Elma
Castro Rodriguez, Javier
Soto Escribano, Pilar
Iglesias Flores, Eva
Marin Pedrosa, Sandra
Benitez, Jose Manuel
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Sociedad Espanola de Patologia Digestiva
Metrics
Export
Abstract
Mesalazine is the most widely used aminosalicylate for induction and maintenance of remission in patients with mild-to-moderate ulcerative colitis (UC). Drug-induced hypersensitivity pneumonitis is considered very rare (< 1/10 000 patients).
Description
MeSH Terms
Anti-inflammatory agents, non-steroidal
COVID-19
Colitis, ulcerative
Humans
Lung diseases, interstitial
Mesalamine
COVID-19
Colitis, ulcerative
Humans
Lung diseases, interstitial
Mesalamine
DeCS Terms
Alveolitis alérgica extrínseca
Colitis ulcerosa
Mantenimiento
Mesalamina
Pacientes
Preparaciones farmacéuticas
Colitis ulcerosa
Mantenimiento
Mesalamina
Pacientes
Preparaciones farmacéuticas
CIE Terms
Keywords
Mesalazine, Lung injury, Ulcerative colitis
Citation
Serrano AA, Jiménez EG, Rodríguez JC, Escribano PS, Flores EI, Pedrosa SM, et al. Mesalazine induced interstitial pneumonitis in the COVID era. Revista Española de Enfermedades Digestivas [Internet]. 1 de enero de 2022